These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19058026)

  • 1. Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences.
    Shankar PR; Humagain B; Piryani RM; Jha N; Osti B
    Pharm World Sci; 2009 Apr; 31(2):241-5. PubMed ID: 19058026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can drug utilization help in promoting the more rational use of medicine? Experiences from Western Nepal.
    Shankar PR; Mishra P; Subish P; Upadhyay DK
    Pak J Pharm Sci; 2007 Jul; 20(3):243-48. PubMed ID: 17545111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.
    Fadare JO; Ogunleye O; Obiako R; Orubu S; Enwere O; Ajemigbitse AA; Meyer JC; Enato E; Massele A; Godman B; Gustafsson LL
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1255-1262. PubMed ID: 30451035
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 6. A survey of drug and therapeutics committees operating in Ireland.
    Ferrando MC; Henman MC
    J Clin Hosp Pharm; 1986 Apr; 11(2):131-40. PubMed ID: 3711361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational drug use in hospital settings - areas that can be changed.
    Religioni U; Pakulska T
    J Med Econ; 2020 Oct; 23(10):1205-1208. PubMed ID: 32715825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary challenges and novel strategies for health-system formulary management.
    Heindel GA; McIntyre CM
    Am J Health Syst Pharm; 2018 Apr; 75(8):556-560. PubMed ID: 29626005
    [No Abstract]   [Full Text] [Related]  

  • 13. Formulary management as a tool to improve medication use and gain physician support.
    Lehmann DF; Guharoy R; Page N; Hirschman K; Ploutz-Snyder R; Medicis J
    Am J Health Syst Pharm; 2007 Mar; 64(5):464-6. PubMed ID: 17322158
    [No Abstract]   [Full Text] [Related]  

  • 14. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2005 Feb; 62(4):378-90. PubMed ID: 15745890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing Hospital Formulary System in Nepal.
    Khadka S; Saeed H; Shahi J; Bajgain Y; Yadav TP; Gupta RP
    J Nepal Health Res Counc; 2020 Sep; 18(2):337-339. PubMed ID: 32969408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, Attitude and Practice Regarding Pharmacovigilance and Consumer Pharmacovigilance among Consumers at Lalitpur District, Nepal.
    Jha N; Rathore DS; Shankar PR; Bhandary S; Alshakka M; Gyawali S
    J Nepal Health Res Counc; 2017 Jan; 15(1):31-37. PubMed ID: 28714489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical approach to grading evidence for formulary recommendations.
    Ansani NT; Fedutes-Henderson BA; Skledar SJ; Branch R; Sirio CA; Smitherman T; Weber RJ
    Am J Health Syst Pharm; 2005 Jul; 62(14):1498-501. PubMed ID: 15998932
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and Therapeutics Committees in Australia: expected and actual performance.
    Weekes LM; Brooks C
    Br J Clin Pharmacol; 1996 Nov; 42(5):551-7. PubMed ID: 8951185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.